Ipsen Biopharmaceuticals has retained The Chase Group once again to work with their commercial leadership as they build world class marketing organizations for both the neurology and oncology business units. Current talent searches are underway for senior marketers with a track record of success with the HCP and patient/caregiver audiences.
Ipsen Biopharmaceuticals, Inc., is headquartered in Basking Ridge, New Jersey. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases in three franchises: neurology, endocrinology and uro-oncology.
Ipsen Retains The Chase Group for Senior Marketers
Ipsen Biopharmaceuticals has retained The Chase Group once again to work with their commercial leadership as they build world class marketing organizations for both the neurology and oncology business units. Current talent searches are underway for senior marketers with a track record of success with the HCP and patient/caregiver audiences.
Ipsen Biopharmaceuticals, Inc., is headquartered in Basking Ridge, New Jersey. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases in three franchises: neurology, endocrinology and uro-oncology.
- Categories: Biotechnology, Life Sciences, Pharmaceutical
-
The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader
Ionis Pharmaceuticals has a 35-year track record of perfecting and advancing RNA-targeted drug discovery and development. Projecting a vast number of new transformational products on… -
The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,… -
The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate… -
The Chase Group Secures Teng Jin Ong for Genmab
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new clinical development medical executive as they work to pioneer the… -
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… -
Leadership Team Grows at Biologics Consulting Through Partnership With The Chase Group
Biologics Consulting, currently experiencing a season of growth, retained The Chase to build out their leadership team. Tasked with identifying a Regulatory Project Management Lead,…